van den Broek M, Huitema A, van Hasselt J, Groenendaal F, Toet M, Egberts T
Clin Pharmacokinet. 2011; 50(7):461-9.
PMID: 21651313
DOI: 10.2165/11589160-000000000-00000.
PENTECOST B, De Giovanni J, Lamb P, Cadigan P, Evemy K, Flint E
Br Heart J. 1981; 45(1):42-7.
PMID: 7459164
PMC: 482487.
DOI: 10.1136/hrt.45.1.42.
Bax N, Tucker G, Woods H
Br J Clin Pharmacol. 1980; 10(4):353-61.
PMID: 7448106
PMC: 1430088.
DOI: 10.1111/j.1365-2125.1980.tb01771.x.
Brown J, SHAND D
Clin Pharmacokinet. 1982; 7(2):125-48.
PMID: 7039925
DOI: 10.2165/00003088-198207020-00003.
Follath F, Ganzinger U, Schuetz E
Clin Pharmacokinet. 1983; 8(1):63-82.
PMID: 6404580
DOI: 10.2165/00003088-198308010-00004.
Comparison of drug dosing methods.
Burton M, Vasko M, Brater D
Clin Pharmacokinet. 1985; 10(1):1-37.
PMID: 3882303
DOI: 10.2165/00003088-198510010-00001.
Free drug concentration monitoring in clinical practice. Rationale and current status.
Svensson C, Woodruff M, BAXTER J, Lalka D
Clin Pharmacokinet. 1986; 11(6):450-69.
PMID: 3542337
DOI: 10.2165/00003088-198611060-00003.
The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S, Gagne G, Pineau M
Clin Pharmacokinet. 1987; 13(5):293-316.
PMID: 2891461
DOI: 10.2165/00003088-198713050-00002.
Arrhythmia prophylaxis after acute myocardial infarction: a decade of controversy.
Harrison D
Cardiovasc Drugs Ther. 1989; 2(6):783-9.
PMID: 2488092
DOI: 10.1007/BF00133208.
Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
Krejcy K, Krumpl G, Todt H, Raberger G
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(2):213-8.
PMID: 1448183
DOI: 10.1007/BF00165304.
Lignocaine: a new technique for intravenous administration.
Levy R, Charuzi Y, Mandel W
Br Heart J. 1977; 39(9):1026-8.
PMID: 907767
PMC: 483363.
DOI: 10.1136/hrt.39.9.1026.
Clinical pharmacokinetics of lignocaine.
Benowitz N, Meister W
Clin Pharmacokinet. 1978; 3(3):177-201.
PMID: 350470
DOI: 10.2165/00003088-197803030-00001.
Bretylium and dobutamine in the treatment of coronary artery disease.
Frishman W
Bull N Y Acad Med. 1979; 55(8):798-809.
PMID: 290401
PMC: 1807694.
